Página principal   |  Sobre esta colección  |  Ayuda  |  Aclarar       Inglés  |  Francés  |  Español  
Documento completo
Capítulo completo
Expandir índice
Ir a la sección anterior Ir a la siguiente sección

cerrar este libroWHO Recommended Surveillance Standards (WHO; 1999; 157 pages)
Ver el documentoAcknowledgements
Ver el documentoAcronyms
Ver el documentoIntroduction
Ver el documentoNational Coordination of Communicable Disease Surveillance
Ver el documentoExplanatory notes
Ver el documentoSurveillance activities: criteria and WHO Department
Ver el documentoCommunicable disease contacts in Regional Offices
abrir esta carpeta y ver su contenidoDiseases
cerrar esta carpetaSyndromes
Ver el documentoAcute haemorrhagic fever syndrome
Ver el documentoAcute lower respiratory tract infections (aLRTI) and Pneumonia
Ver el documentoAcute (watery) diarrhoea
Ver el documentoAcute (bloody) diarrhoea
Ver el documentoAntimicrobial resistance
Ver el documentoAnti-tuberculosis drug resistance
Ver el documentoFoodborne diseases
Ver el documentoSexually transmitted diseases/syndromes
Ver el documentoAnnex 1 Software free and in the public domain
Ver el documentoAnnex 2 Proposed surveillance definitions
Ver el documentoAnnex 3 Role and use of Geographic Information Systems (GIS) and mapping for epidemiological surveillance

Acute haemorrhagic fever syndrome


Acute haemorrhagic fever syndromes can be attributable to dengue (dengue haemorrhagic fever), Ebola-Marburg viral diseases, Lassa fever, yellow fever, Rift Valley fever, hantavirus infections, Crimean-Congo haemorrhagic fever, and other viral, bacterial or rickettsial diseases with a potential to produce epidemics. All cases of acute haemorrhagic fever syndrome, whether single or in clusters, should therefore be notified early, without waiting for the causal agent to be identified, according to the syndromic approach of revised International Health Regulations (IHR). Surveillance of acute haemorrhagic fever syndrome is aimed at early detection of cases in order to avoid epidemics and the possible international spread of the disease.


Clinical case description (revised IHR)

Acute onset of fever of less than 3 weeks duration in a severely ill patient and

any 2 of the following


• haemorrhagic or purpuric rash
• epistaxis
• haematemesis
• haemoptysis
• blood in stools
• other haemorrhagic symptom and no known predisposing host factors for haemorrhagic manifestations


Note: During epidemics, most infected patients do not show haemorrhagic symptoms and a specific case definition, according to the suspected or proven disease, has to be used (see disease-specific case definitions in this manual for Ebola, Lassa, dengue, and yellow fever, or specific WHO Outbreak Control Guidelines*).


* Available for Ebola haemorrhagic fever, dengue haemorrhagic fever, yellow fever.


Immediate case-based reporting of acute haemorrhagic fever syndrome, whether occurring singly or in clusters, from peripheral to intermediate and central level, in order to ensure rapid investigation and laboratory confirmation.

All cases must be investigated, with contact tracing. Blood samples and appropriate clinical specimens must be collected to confirm a diagnosis as rapidly as possible.


Case-based data


• Unique identifier, name, age, sex
• Geographical information
• Profession, place of work
• Date of onset of syndrome
• Date of hospitalization
• Date of death if relevant
• Number of contacts with ill patients
• Date and type of contacts with other cases
• Clinical samples taken for laboratory investigation (including date of sampling)



• Number of cases
• Number of deaths
• Number of contacts and aggregated vector and/or animal reservoir data as appropriate



Total cumulative number of cases

Total cumulative number of deaths

Geographic distribution of cases

Date of reported cases

During outbreaks


• Total cumulative number of cases
• Epidemic curve
• Total cumulative number of deaths
• Case-fatality rate
• Current number of patients
• Geographic distribution of cases
• Attack rate (age-specific if possible)
• Current number of hospitalized patients
• Date of reporting of last identified case
• Date of death or hospital discharge of the last reported case
• Contacts:
• Current number of contacts requiring follow up
• Current number of contacts actually under follow-up
• Geographic distribution of contacts


Routine surveillance data


• Detect an isolated case or an outbreak and take appropriate control measures

During outbreaks


• Active case finding and contact tracing:
• Identify all cases and contacts
• Assess and monitor the spread of an outbreak
• Evaluate control measures
• Provide basis for research


Acute haemorrhagic fever syndrome is one of the syndromes subject to notification to WHO in the revised International Health Regulations (pending implementation).


Regional Offices

See Regional Communicable Disease contacts on section "Communicable disease contacts in Regional Offices".

Headquarters: 20 Avenue Appia, CH-1211 Geneva 27, Switzerland,

Communicable Diseases Surveillance and Response (CSR)


E-mail: arthurr@who.ch / outbreak@who.ch
Tel: (41 22) 791 2658/2636/2111
Fax: (41 22) 791 48 78
Ir a la sección anterior Ir a la siguiente sección

Por favor envíe sus comentarios   Inglés  |  Francés  |  Español